-
1Academic Journal
Authors: D. Sh. Polatova, A. Yu. Madaminov, A. V. Savkin, A. I. Nurzhabov, N. K. Asamedinov, D. A. Ibragimova, R. R. Davletov, S. K. Nasirov, Д. Ш. Полатова, А. Ю. Мадаминов, А. В. Савкин, А. И. Нуржабов, Н. К. Асамединов, Д. А. Ибрагимова, Р. Р. Давлетов, С. К. Насиров
Source: Head and Neck Tumors (HNT); Том 13, № 2 (2023); 44-56 ; Опухоли головы и шеи; Том 13, № 2 (2023); 44-56 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2023-13-2
Subject Terms: молекулярный маркер, oropharyngeal squamous cell carcinoma, p16 INk4a, programmed death-ligand 1, р53, immunohistochemical analysis, protein expression, molecular marker, плоскоклеточная карцинома ротоглотки, лиганд рецептора про- граммируемой клеточной гибели 1, иммуногистохимическое исследование, экспрессия белка
File Description: application/pdf
Relation: https://ogsh.abvpress.ru/jour/article/view/888/585; De Martel C., Georges D., Bray F. et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 2020;8(2):e180–90. DOI:10.1016/S2214-109X(19)30488-7; Bravo I.G., Félez-Sánchez M. Papillomaviruses: viral evolution, cancer and evolutionary medicine. Evol Med Pub Health 2015;1:32–51. DOI:10.1093/emph/eov003; Chaturvedi A.K., Engels E.A., Pfeiffer R.M. et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29(32):4294–301. DOI:10.1200/JCO.2011.36.4596; Gillison M.L., Chaturvedi A.K., Anderson W. F., Fakhry C. Epidemiology of human papillomaviruspositive head and neck squamous cell carcinoma. J Clin Oncol 2015;33(29):3235–42. DOI:10.1200/JCO.2015.61.6995; Gelwan E., Malm I.J., Khararjian A. et al. Nonuniform distribution of high-risk human papillomavirus in squamous cell carcinomas of the oropharynx: rethinking the anatomic boundaries of oral and oropharyngeal carcinoma from an oncologic HPV perspective. Am J Surg Pathol 2017;41(12):1722–8. DOI:10.1097/PAS.0000000000000929; Castellsagué X., Alemany L., Quer M. et al. ICO international HPV in Head and Neck Cancer Study Group. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 Patients. J Natl Cancer Inst 2016;108(6):djv403. DOI:10.1093/jnci/djv403; Carlander A.F., Jakobsen K.K., Bendtsen S.K. et al. A contemporary systematic review on repartition of HPV-positivity in oropharyngeal cancer worldwide. Viruses 2021;13:1326. DOI:10.3390/v13071326; Berman T.A., Schiller J.T. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer 2017;123(12):2219–29. DOI:10.1002/cncr.30588; Sinha P., Karadaghy O.A., Doering M.M. et al. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: a systematic review and meta-analysis. Oral Oncol 2018;86:121–31. DOI:10.1016/j.oraloncology.2018.09.018; Lewis J.S., Beadle B., Bishop J.A. et al. Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists. Arch Pathol Lab Med 2018;142(5): 559–97. DOI:10.5858/arpa.2017-0286-CP; De la Iglesia J.V., Slebos R.J.C., Martin-Gomez L. et al. Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma. Clin Cancer Res 2020;26(6):1474–85. DOI:10.1158/1078-0432.CCR-19-1769; Budu V.A., Decuseară T., Balica N.C. et al. The role of HPV infection in oropharyngeal cancer. Rom J Morphol Embryol 2019;60(3):769–73.; Dogan S., Xu B., Sumit Middha S. et al. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. Int J Cancer 2019;145(11):3152–62.; Wagner S., Prigge E.S., Wuerdemann N. et al. Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation. Br J Cancer 2020;123(7):1114–22. DOI:10.1038/s41416-020-0964-x; Пхешхова Б.Г., Мудунов А.М., Азизян Р.И. и др. Оценка распространенности ВПЧ-положительного плоскоклеточного рака ротоглотки на примере отдельной выборки в Российской Федерации. Опухоли головы и шеи 2022;12(1):72–8. DOI:10.17650/2222-1468-2022-12-1-72-78; Serra S., Chetty R. p16. J Clin Pathol 2018;71(10):853–8. DOI:10.1136/jclinpath-2018-205216; Kono T., Laimins L. Genomic instability and DNA damage repair pathways induced by human papillomaviruses. Viruses 2021;13(9):1821. DOI:10.3390/v13091821; Lechner M., Liu J., Masterson L., Fenton T.R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 2022;19(5):306–27. DOI:10.1038/s41571-022-00603-7; Hu J., Cao J., Topatana W., Juengpanich S. et al. Targeting mutant p53 for cancer therapy: direct and indirect strategies. J Hematol Oncol 2021;14(1):157. DOI:10.1186/s13045-021-01169-0; Caponio V.C.A., Troiano G., Adipietro I. et al. Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer. Br J Cancer 2020;123(8):1302–14. DOI:10.1038/s41416-020-0984-6; Mittal S., Banks L. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mutat Res Rev 2017;772:23–35. DOI:10.1016/j.mrrev.2016.08.001; Munari E., Mariotti F.R., Quatrini L. et al. PD-1/PD-L1 in cancer: pathophysiological, diagnostic and therapeutic aspects. Int J Mol Sci 2021;22:5123. DOI:10.3390/ijms22105123; Salmaninejad A., Khoramshahi V., Azani A. et al. PD-1 and cancer: molecular mechanisms and polymorphisms. Immunogenetics 2017;70(2):73–86. DOI:10.1007/s00251-017-1015-5; Steinbach A.,Riemer A.B. Immune evasion mechanisms of human papillomavirus: an update. Int J Cancer 2018;142(2):224–9. DOI:10.1002/ijc.31027; Paolino G., Pantanowitz L., Barresi V. et al. PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy. Pathol Res Pract 2021;226:153605. DOI:10.1016/j.prp.2021.153605; Yang W.F., Wong M.C.M., Thomson P.J. et al. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 2018;86:81–90. DOI:10.1016/j.oraloncology.2018.09.016; Solomon B., Young R.J., Bressel M. et al. Prognostic significance of PD-L1(+) and CD8(+) immune cells in HPV(+) oropharyngeal squamous cell carcinoma. Cancer Immunol Res 2018;6(3):295– 304. DOI:10.1158/2326-6066.CIR-17-0299; Lyford-Pike S., Peng S., Young G.D. et al. Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res 2013;73(6):1733–41. DOI:10.1158/0008-5472.CAN-12-2384; https://ogsh.abvpress.ru/jour/article/view/888
-
2